Relapse and severe graft-versus-host-disease have a negative impact on long-term symptoms and quality of life of patients three years after allogeneic haematopoietic stem cell transplantation

被引：0
|
作者：
Oerlemans, S. [1 ]
Verheij, F. [2 ]
Wit, T. Nagtegaal-de [2 ]
Nijssen, K. [2 ]
Kramer-Smittenberg, L. [2 ]
Schoonhoven-Bos, L. [2 ]
Van Rhenen, A. [2 ]
Van Hussen-Daenen, L. [2 ]
Van der Wagen, L. [2 ]
De Witte, M. [2 ,3 ]
Kuball, J. [2 ,3 ]
机构：
[1] Netherlands Comprehens Canc Org IKNL, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P480
引用
收藏
页码：360 / 360
页数：1
相关论文
共 50 条
  • [31] Acute Graft versus Host Disease in Beta Thalassemia Patients Following Allogeneic Haematopoietic Stem Cell Transplantation
    Rafique, Nabila
    Ali, Asghar
    Ghaffor, Tariq
    Khattak, Tariq Azam
    Asghar, Muhammad Bilal
    Chaudhry, Qammar-un- Nisa
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (04): : 480 - 483
  • [32] Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantation
    Mohty, M
    Faucher, C
    Blaise, D
    LEUKEMIA, 2005, 19 (04) : 500 - 503
  • [33] Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation
    Partanen, Jukka
    Hyvarinen, Kati
    Bickeboller, Heike
    Bogunia-Kubik, Katarzyna
    Crossland, Rachel E.
    Ivanova, Milena
    Perutelli, Francesca
    Dressel, Ralf
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [34] Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study
    Mohty, M
    Kuentz, M
    Michallet, M
    Bourhis, JH
    Milpied, N
    Sutton, L
    Jouet, JP
    Attal, M
    Bordigoni, P
    Cahn, JY
    Boiron, JM
    Blaise, D
    BLOOD, 2002, 100 (09) : 3128 - 3134
  • [35] Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantation
    M Mohty
    C Faucher
    D Blaise
    Leukemia, 2005, 19 : 500 - 503
  • [36] Symptoms, Cytokines, and Quality of Life in Patients Diagnosed With Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
    Kelly, Debra Lynch
    Lyon, Debra E.
    Ameringer, Suzanne A.
    Elswick, Ronald K., Jr.
    McCarty, John M.
    ONCOLOGY NURSING FORUM, 2015, 42 (03) : 265 - 275
  • [37] CERVICAL CYTOLOGY SCREENING IN LONG-TERM SURVIVORS OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH GENITAL GRAFT VERSUS HOST DISEASE
    Shanis, D. L.
    Pophali, P.
    Koklanaris, E.
    Battiwalla, M.
    Barrett, J.
    Stratton, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S282 - S282
  • [38] Significance of prognostic scores, risk factors and chronic graft-versus-host-disease (cGVHD) on outcome after allogeneic haematopoietic stem cell transplantation (HSCT) for myelofibrosis
    Ditschkowski, M.
    Elmaagacli, A. H.
    Trenschel, R.
    Steckel, N. K.
    Gromke, T.
    Koldehoff, M.
    Beelen, D. W.
    ONKOLOGIE, 2011, 34 : 206 - 206
  • [39] Effect of acute graft-versus-host disease on the overall survival after allogeneic haematopoietic stem cell transplantation
    Pevna, M.
    Krejci, M.
    Coupek, P.
    Klabusay, M.
    Mayer, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S144 - S145
  • [40] Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease
    S Kulkarni
    R Powles
    B Sirohi
    J Treleaven
    R Saso
    C Horton
    A Atra
    M Ortin
    C Rudin
    S Goyal
    S Sankpal
    S Meller
    C R Pinkerton
    J Mehta
    S Singhal
    Bone Marrow Transplantation, 2003, 32 : 165 - 170
12345